BREAKING NEWS: Moderna CEO says the firm could get emergency FDA approval for a vaccine in December if trial results results expected this month are successful
- Moderna Inc’s CEO says the company is expecting the interim results of its coronavirus vaccine trial this month
- If the results are positive, along with the two months of safety data, the firm will be ready to apply for emergency use approval with the FDA in December
- It comes just days after Pfizer Inc announced that 90% more people who received two injections of its vaccine were protected compared to a placebo
Moderna Inc says it expects to know if its experimental coronavirus vaccine is effective this month.
At the Credit Suisse Virtual Healthcare Conference on Wednesday, CEO Stéphane Bancel said interim results of the company’s trial are due in November.
Provided the results are positive, Bancel added that Moderna should be able to apply for Emergency Use Authorization (EUA) with the US Food and Drug Administration (FDA) by early December.
The news just comes just two days after Pfizer Inc announced its COVID-19 vaccine was 90 percent more effective at protecting trial participants from infection than a placebo, according to early data.
Moderna Inc’s CEO says the company is expecting the interim results of its coronavirus vaccine trial this month. Pictured: A sign marks the headquarters of Moderna in Cambridge, Massachusetts, May 2020
This is a breaking news story and will be updated.